Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection

Human Pathology

Volumn 28, Issue 4, 1997, Pages 434-442

  Cool, Carlyne D ^a   Kennedy, Denise ^b   Voelkel, Norbert F ^b   Tuder, Rubin M ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

AIDS; plexiform vascular lesions; pulmonary hypertension; scleroderma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; MALE; PATHOGENESIS; PULMONARY HYPERTENSION; SCLERODERMA; VASCULITIS;

EID: 0030987082     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90032-0     Document Type: Article

References (40)

1. Loyd JE, AtkinsonJB, Pietra GG, et al: Heterogeneity of pathologic lesions in familial primary pulmonary hypertension. Am Rev Respir Dis 38:952-957, 1988
2. Wagenvoort CA, Wagenvoort N: Primary pulmonary hypertension: A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation XLII:1163-1184, 1970
3. Bjornsson J, Edwards WD: Primary pulmonary hypertension: A histopathologic study of 80 cases. Mayo Clin Proc 60:16-25, 1985
4. Pietra GG, Ruttner JR: Specificity of pulmonary vascular lesions in primary pulmonary hypertension: A reappraisal. Respiration 52:81-85, 1987
5. Yamaki S, Wagenvoort CA: Comparison of primary plexogenic arteriopathy in adults and children: A morphometric study in 40 patients. Br Heart J 54:428-434, 1985
6. Edwards WD: Pathology of pulmonary hypertension. Cardiovasc Clin 18:321-354, 1987
7. Saunders JB, Constable TJ, Heath D, et al: Pulmonary hypertension complicating portal vein thrombosis. Thorax 34:281-283, 1978
8. Salyer W, Hutchins GM: Glomoid lesions in systemic arteries in malignant hypertension. Arch Pathol 97:104-106, 1974
9. Tuder RM, Groves B, Badesch DB, et al: Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 144:275-285, 1994
10. Rabinovitch M: Mechanisms of pulmonary hypertension in chronic high flow states, in Weir EK, Reeves JT (eds): Pulmonary Physiology and Pathophysiology. New York, NY, Marcel Decker, 1989, pp 469-511
11. Rich S, Brundage BH: Pulmonary hypertension: A cellular basis for understanding the pathophysiology and treatment. J Am Coll Cardiol 14:545-550, 1989
12. McCormick D, Chong H, Hobbs C, et al: Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 22:355-360, 1993
13. Jamison BM, Michel RP: Different distribution of plexiform lesions in primary and secondary pulmonary hypertension. HUM PATHOL 26:987-993, 1995
14. Naeye RL, Vennart GP: The structure and significance of pulmonary plexiform structures. Am J Pathol 36:593-605, 1960
15. Hogg JC: Primary pulmonary hypertension. Chest 93:172S-175S, 1988 (suppl)
16. McDonnell PJ, Toye PA, Hutchins GM: Primary pulmonary hypertension and cirrhosis: Are they related? Am Rev Respir Dis 127:437-441, 1983
17. Olivari M-T: Southwestern Internal Medicine Conference: Primary pulmonary hypertension. Am J Med Sci 302:185-198, 1991
18. Mette SA, Palevsky HI, Pietra GG, et al: Primary pulmonary hypertension in association with human immunodeficiency virus infection: A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis 145:1196-1200, 1992
19. Speich R, Jenni R, Opravil M, et al: Primary pulmonary hypertension in HIV infection. Chest 100:1268-1271, 1991
20. Jacques C, Richmond G, Tierney L, et al: Primary pulmonary hypertension and human immunodeficiency virus infection in a nonhemophiliac man. HUM PATHOL 23:191-194, 1992
21. Kim KK, Factor SM: Mernbranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome. Pathology 18:1293-1296, 1987
22. Smith P, Heath D: Electron microscopy of the plexiform lesion. Thorax 34:177-186, 1979
23. Heath D, Smith P, GosneyJ, et al: The pathology of the early and late stages of primary pulmonary hypertension. Br Heart J 58:204-213, 1987
24. Monacci WT, Merrill MJ, Oldfield EH: Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264:C995-C1002, 1993
25. Jakeman LB, Winer J, Bennett GL, et al: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253, 1992
26. Shweiki D, Itin A, Soffer D, et al: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992
27. Burke AP, Farb A, Virmani R: The pathology of primary pulmonary hypertension. Mod Pathol 4:269-282, 1991
28. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am Soc Invest Pathol 147:1:9-19, 1995
29. Cool C, Voelkel FN, Tuder RM: Three-dimensional reconstruction of the plexiform lesions in pulmonary hypertension. Am J Respir Crit Care Med 153:A85, 1996
30. Caslin AW, Heath D, Madden B, et al: The histopathology of 36 cases of plexogenic pulmonary arteriopathy. Histopathology 16:9-19, 1990
31. Murrell DF: A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28:78-85, 1993
32. LeRoy EC: A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis 51:286-288, 1992
33. Kahaleh MB, LeRoy EC: The immune basis for human fibrotic diseases, especially scleroderma (systemic sclerosis). Clin Asp Immun 3:19-28, 1989
34. Jiminez SA, Batuman O: Immunopathogenesis of systemic sclerosis: Possible role of retroviruses. Autoimmunity 16:225-233, 1993
35. Smiley D: Southwestern Internal Medicine Conference: The many faces of scleroderma. Am J Med Sci 304:319-333, 1992
36. Cohen S, Johnson AR, Hurd E: Cytotoxicity of sera from patients with scleroderma: Effects on human endothelial cells and fibroblasts in culture. Arthritis Rheum 26:170-178, 1983
37. Hofman FM, Wright AD, Dohadwala MM, et al: Exogenous tat protein activates human endothelial cells. Blood 82:2774-2780, 1993
38. Rosenberg ZF, Fauci AS: Immunopathogenic mechanisms of HIV infection: Cytokine induction of HIV expression. Immunol Today 11:176-180, 1990
39. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 262:1011-1018, 1993
40. Wagenvoort CA, Mooi WJ: Controversies and potential errors in the histological evaluation of pulmonary vascular disease, in Wagenvoort CA, Denolin H (eds): Pulmonary Circulation, Advances and Controversies. New York, NY, Elsevier Science Publishing, 1989, pp 7-26